Q4 2024

Filed Mar 28, 2025 · 10-K · 87 days after period end · 0001062993-25-006485

Q4 2024 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net Income

-$3.54M

derivedno prior Q4 2023 on file

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Incomederived-$3,585,449—

Same quarter

no prior Q4 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2024 · filed Mar 28, 2025 · 87 d after period end

Medicus Pharma Ltd. · CIK 1997296 · Engraved from SEC EDGAR